BCL2 and liver cancer: In vitro experiments with the human liver cancer cell line HepG2 showed that EVs derived from L. rhamnosus PTCC 1637 prevent liver cancer and significantly increase the apoptosis index (Bax/Bcl-2 ratio), inducing cancer cell death (51).